… the population PK of ampicillin in 73 neonates as young as 24 weeks of gestation and up
to 28 days PNA. This broad age spectrum enabled the construction of a population PK model …

… and pharmacodynamic changes in neonates receiving CH. Therefore, the aim of this … the
population pharmacokinetics and pharmacodynamic target attainment of ampicillin in neonates …

… essential medicines for children. Methods… population PK model of piperacillin, amoxicillin,
ampicillin, cefotaxime, ceftriaxone, cloxacillin, imipenem or meropenem in neonates or children…

… analysis is that ampicillin PK parameters were not estimated directly in our study population
but were predicted using a population PK model based on a similar patient population. The …

… is the major pathway for amoxicillin elimination 3 in (pre)term neonates. The population
pharmacokinetic parameters of amoxicillin found in the present study are similar to the results of …

… Dried blood spot (DBS) is a practical sampling strategy for pharmacokinetic studies in
neonates. The utility of DBS to determine the population pharmacokinetics (pop-PK) of ampicillin, …

… Characterization of the population pharmacokinetics of ampicillin in neonates using an
opportunistic study design. Antimicrob Agents Chemother. 2014; 58:3013–3020. …

… to evaluate the population pharmacokinetics of intravenous amoxicillin in infants and suggest
… Dosage recommendations of amoxicillin for use in infants are extrapolated from ampicillin …

… As hypothermic treatment can alter the PK of certain drugs,17 studying its potential effect on
… asphyxiated newborns treated with moderate hypothermia and describe the population PK …

… the effects and pharmacokinetics of ampicillin in neonates and infants. … ampicillin population
pharmacokinetic parameters for 13 neonates, and Table.2 shows the ampicillin population …